vs
Side-by-side financial comparison of MEDIFAST INC (MED) and P10, Inc. (PX). Click either name above to swap in a different company.
P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $75.1M, roughly 1.1× MEDIFAST INC). On growth, P10, Inc. posted the faster year-over-year revenue change (-4.7% vs -36.9%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $-6.6M). Over the past eight quarters, P10, Inc.'s revenue compounded faster (10.7% CAGR vs -34.4%).
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.
P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.
MED vs PX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $81.0M |
| Net Profit | — | $9.5M |
| Gross Margin | 69.4% | — |
| Operating Margin | -10.4% | 31.9% |
| Net Margin | — | 11.7% |
| Revenue YoY | -36.9% | -4.7% |
| Net Profit YoY | — | 79.0% |
| EPS (diluted) | $-1.64 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $81.0M | ||
| Q3 25 | $89.4M | $75.9M | ||
| Q2 25 | $105.6M | $72.7M | ||
| Q1 25 | $115.7M | $67.7M | ||
| Q4 24 | $119.0M | $85.0M | ||
| Q3 24 | $140.2M | $74.2M | ||
| Q2 24 | $168.6M | $71.1M | ||
| Q1 24 | $174.7M | $66.1M |
| Q4 25 | — | $9.5M | ||
| Q3 25 | $-2.3M | $2.1M | ||
| Q2 25 | $2.5M | $3.4M | ||
| Q1 25 | $-772.0K | $4.5M | ||
| Q4 24 | — | $5.3M | ||
| Q3 24 | $1.1M | $1.4M | ||
| Q2 24 | $-8.2M | $7.0M | ||
| Q1 24 | $8.3M | $5.0M |
| Q4 25 | 69.4% | — | ||
| Q3 25 | 69.5% | — | ||
| Q2 25 | 72.6% | — | ||
| Q1 25 | 72.8% | — | ||
| Q4 24 | 74.1% | — | ||
| Q3 24 | 75.4% | — | ||
| Q2 24 | 73.2% | — | ||
| Q1 24 | 72.8% | — |
| Q4 25 | -10.4% | 31.9% | ||
| Q3 25 | -4.6% | 14.1% | ||
| Q2 25 | -1.0% | 24.4% | ||
| Q1 25 | -1.1% | 16.6% | ||
| Q4 24 | 0.6% | 26.9% | ||
| Q3 24 | 1.5% | 11.9% | ||
| Q2 24 | -4.7% | 23.7% | ||
| Q1 24 | 4.5% | 18.3% |
| Q4 25 | — | 11.7% | ||
| Q3 25 | -2.5% | 2.8% | ||
| Q2 25 | 2.3% | 4.7% | ||
| Q1 25 | -0.7% | 6.7% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | 0.8% | 1.9% | ||
| Q2 24 | -4.8% | 9.8% | ||
| Q1 24 | 4.8% | 7.6% |
| Q4 25 | $-1.64 | $0.08 | ||
| Q3 25 | $-0.21 | $0.02 | ||
| Q2 25 | $0.22 | $0.03 | ||
| Q1 25 | $-0.07 | $0.04 | ||
| Q4 24 | $0.08 | $0.05 | ||
| Q3 24 | $0.10 | $0.01 | ||
| Q2 24 | $-0.75 | $0.06 | ||
| Q1 24 | $0.76 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.3M | $28.2M |
| Total DebtLower is stronger | — | $373.2M |
| Stockholders' EquityBook value | $198.9M | $403.5M |
| Total Assets | $248.0M | $928.3M |
| Debt / EquityLower = less leverage | — | 0.93× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.3M | $28.2M | ||
| Q3 25 | $173.5M | $40.0M | ||
| Q2 25 | $162.7M | $33.4M | ||
| Q1 25 | $164.6M | $74.4M | ||
| Q4 24 | $162.3M | $67.5M | ||
| Q3 24 | $170.0M | $61.5M | ||
| Q2 24 | $163.5M | $31.2M | ||
| Q1 24 | $156.4M | $29.0M |
| Q4 25 | — | $373.2M | ||
| Q3 25 | — | $393.4M | ||
| Q2 25 | — | $373.0M | ||
| Q1 25 | — | $357.2M | ||
| Q4 24 | — | $319.8M | ||
| Q3 24 | — | $319.4M | ||
| Q2 24 | — | $300.6M | ||
| Q1 24 | — | $314.0M |
| Q4 25 | $198.9M | $403.5M | ||
| Q3 25 | $214.7M | $396.8M | ||
| Q2 25 | $216.0M | $388.9M | ||
| Q1 25 | $211.0M | $374.3M | ||
| Q4 24 | $210.1M | $386.9M | ||
| Q3 24 | $207.3M | $394.1M | ||
| Q2 24 | $205.3M | $396.9M | ||
| Q1 24 | $211.0M | $400.1M |
| Q4 25 | $248.0M | $928.3M | ||
| Q3 25 | $268.2M | $936.0M | ||
| Q2 25 | $269.3M | $932.2M | ||
| Q1 25 | $280.0M | $877.4M | ||
| Q4 24 | $284.2M | $869.3M | ||
| Q3 24 | $291.2M | $857.0M | ||
| Q2 24 | $293.5M | $823.2M | ||
| Q1 24 | $302.8M | $832.8M |
| Q4 25 | — | 0.93× | ||
| Q3 25 | — | 0.99× | ||
| Q2 25 | — | 0.96× | ||
| Q1 25 | — | 0.95× | ||
| Q4 24 | — | 0.83× | ||
| Q3 24 | — | 0.81× | ||
| Q2 24 | — | 0.76× | ||
| Q1 24 | — | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.3M | $23.0M |
| Free Cash FlowOCF − Capex | $-6.6M | $18.1M |
| FCF MarginFCF / Revenue | -8.8% | 22.3% |
| Capex IntensityCapex / Revenue | 1.8% | 6.0% |
| Cash ConversionOCF / Net Profit | — | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | $1.2M | $14.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.3M | $23.0M | ||
| Q3 25 | $12.1M | $-8.6M | ||
| Q2 25 | $-3.4M | $13.4M | ||
| Q1 25 | $3.4M | $-4.7M | ||
| Q4 24 | $-4.9M | $101.0M | ||
| Q3 24 | $9.1M | $27.5M | ||
| Q2 24 | $13.1M | $34.8M | ||
| Q1 24 | $7.3M | $11.0M |
| Q4 25 | $-6.6M | $18.1M | ||
| Q3 25 | $10.8M | $-9.5M | ||
| Q2 25 | $-4.8M | $11.6M | ||
| Q1 25 | $1.9M | $-6.0M | ||
| Q4 24 | $-7.2M | $96.6M | ||
| Q3 24 | $7.7M | $25.2M | ||
| Q2 24 | $11.1M | $33.9M | ||
| Q1 24 | $5.4M | $10.7M |
| Q4 25 | -8.8% | 22.3% | ||
| Q3 25 | 12.0% | -12.6% | ||
| Q2 25 | -4.5% | 15.9% | ||
| Q1 25 | 1.6% | -8.9% | ||
| Q4 24 | -6.1% | 113.6% | ||
| Q3 24 | 5.5% | 34.0% | ||
| Q2 24 | 6.6% | 47.7% | ||
| Q1 24 | 3.1% | 16.2% |
| Q4 25 | 1.8% | 6.0% | ||
| Q3 25 | 1.5% | 1.2% | ||
| Q2 25 | 1.3% | 2.5% | ||
| Q1 25 | 1.3% | 1.9% | ||
| Q4 24 | 1.9% | 5.2% | ||
| Q3 24 | 1.0% | 3.0% | ||
| Q2 24 | 1.1% | 1.3% | ||
| Q1 24 | 1.1% | 0.4% |
| Q4 25 | — | 2.43× | ||
| Q3 25 | — | -4.01× | ||
| Q2 25 | -1.36× | 3.96× | ||
| Q1 25 | — | -1.05× | ||
| Q4 24 | — | 19.12× | ||
| Q3 24 | 8.04× | 19.54× | ||
| Q2 24 | — | 4.98× | ||
| Q1 24 | 0.88× | 2.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MED
Segment breakdown not available.
PX
| Management Fees | $78.1M | 96% |
| Advisory Fees | $1.8M | 2% |
